USANA Health Sciences Inc
$ 21.34
2.55%
06 Feb - close price
- Market Cap 390,113,000 USD
- Current Price $ 21.34
- High / Low $ 21.41 / 20.72
- Stock P/E 23.71
- Book Value 28.90
- EPS 0.90
- Next Earning Report 2026-02-17
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.03 %
- 52 Week High 38.32
- 52 Week Low 18.48
About
USANA Health Sciences, Inc. is a prominent developer and manufacturer of science-based nutritional supplements and personal care products, dedicated to enhancing global health and wellness. Based in Salt Lake City, Utah, the company employs a direct selling model to effectively distribute its offerings across numerous international markets. With a strong commitment to innovation and high-quality standards, USANA has built a robust reputation in the health and wellness sector, strategically positioning itself to seize opportunities in the expanding global demand for premium wellness solutions.
Analyst Target Price
$39.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-05 | 2025-07-21 | 2025-04-28 | 2025-02-04 | 2024-10-22 | 2024-07-23 | 2024-04-30 | 2024-02-06 | 2023-10-24 | 2023-07-25 | 2023-04-25 | 2023-02-07 |
| Reported EPS | -0.36 | 0.74 | 0.73 | 0.64 | 0.56 | 0.54 | 0.86 | 0.87 | 0.59 | 0.89 | 0.95 | 0.66 |
| Estimated EPS | 0.56 | 0.54 | 0.7 | 0.49 | 0.49 | 0.65 | 0.69 | 0.52 | 0.64 | 0.7 | 0.77 | 0.35 |
| Surprise | -0.92 | 0.2 | 0.03 | 0.15 | 0.07 | -0.11 | 0.17 | 0.35 | -0.05 | 0.19 | 0.18 | 0.31 |
| Surprise Percentage | -164.2857% | 37.037% | 4.2857% | 30.6122% | 14.2857% | -16.9231% | 24.6377% | 67.3077% | -7.8125% | 27.1429% | 23.3766% | 88.5714% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-17 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.41 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: USNA
2026-02-02 23:03:00
USANA Health Sciences (USNA) stock has dropped significantly, leading analysts to advise caution. The company is not recommended due to declining revenue, limited distribution channels as a small consumer staples company, and a negative trend in earnings per share. Instead, the article suggests focusing on other high-quality stocks that have shown strong momentum and market-beating returns.
2026-02-02 17:28:15
Kevin Guest, Executive Chairman & CEO of USANA Health Sciences, encourages leaders to embrace Self-Renewal Day by breaking comfort zones for strategic growth. He outlines six steps, including conducting a personal audit, reconnecting with core values, and committing to positive self-talk, to help executives transform their careers and lives. Guest emphasizes that true renewal involves conscious choices and courage to realign for purpose, drawing lessons from his own experiences and his book, "All the Right Reasons."
2026-02-02 12:28:15
USANA Executive Chairman and CEO Kevin Guest observed Self-Renewal Day by encouraging leaders to move beyond their comfort zones for strategic growth. He outlined six steps for personal and professional renewal, including conducting a personal audit, reconnecting with core values, and making courageous decisions. Guest, who once left a music career for leadership, highlighted how proceeds from his book "All the Right Reasons" benefit the USANA Foundation, providing over 112 million meals to date.
2026-02-02 11:28:47
USANA Executive Chairman & CEO Kevin Guest marks Self-Renewal Day by urging business leaders to break comfort zones for strategic growth. He shares six steps for personal and professional renewal, emphasizing the importance of aligning with core values and embracing change. Guest highlights his own journey from aspiring musician to CEO and promotes his book, "All the Right Reasons," which benefits the USANA Foundation.
2026-02-02 07:05:00
On Self-Renewal Day, USANA Health Sciences Executive Chairman & CEO Kevin Guest urges business leaders to break free from comfort zones and pursue strategic growth. Guest, author of "All the Right Reasons," emphasizes that true renewal involves making courageous decisions, realigning with core values, and embracing discomfort for long-term fulfillment. He outlines six steps, including conducting a personal audit, making courageous decisions, and reframing resilience, to help leaders elevate their performance and drive purposeful growth.
2026-01-19 06:26:52
Sidoti Csr has increased its Q3 2026 EPS estimate for USANA Health Sciences (NYSE:USNA) to $0.54 and projects FY2026 EPS at $1.95, while the consensus full-year estimate stands at $2.45. The company recently missed Q3 expectations, reporting -$0.15 EPS against an estimated $0.47, and provided FY2025 guidance of $1.73 EPS. Market sentiment remains negative with an average "Reduce" rating from analysts and recent insider selling activity.
